JUNYA FUJIMOTO to Protein Kinase Inhibitors
This is a "connection" page, showing publications JUNYA FUJIMOTO has written about Protein Kinase Inhibitors.
Connection Strength
0.033
-
Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer. J Clin Invest. 2023 01 17; 133(2).
Score: 0.019
-
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer. Cancer Discov. 2019 05; 9(5):646-661.
Score: 0.014